In contrast, CD4+ T cells were increased and clustered at sites of fibrosis in the livers of the NAFLD patients (who were in the late stage of disease with evidence of NASH, cirrhosis and HCC) we studied. Here, CD4 is linked to metabolic dysfunction-associated steatotic liver disease.